ENDPOINTS

GSK to research link between Shingrix and dementia risk in UK partnership

GSK is teaming up with a pair of UK-based research bodies to conduct a “real world evidence analysis” to see if its shingles vaccine Shingrix can cut the risk of developing dementia. Together with the ...

Mar 25, 2025 - 11:50
 0
GSK to research link between Shingrix and dementia risk in UK partnership
GSK is teaming up with a pair of UK-based research bodies to conduct a “real world evidence analysis” to see if its shingles vaccine Shingrix can cut the risk of developing dementia. Together with the ...
Read More

Tags:

Previous Article

Extreme heat is changing the way we live. This is how

Next Article

Best solar binoculars 2025: Observe the partial solar eclipse this week

Related Posts

Pharma-backed Mission Therapeutics stops preclinical operations, focuses on two clinical assets

Pharma-backed Mission Therapeutics stops preclinical op...

Feb 27, 2025  0

Otsuka makes pipeline changes; Oculis reveals $100M offering

Otsuka makes pipeline changes; Oculis reveals $100M off...

Feb 14, 2025  0

AstraZeneca puts $2.5B toward first vaccine factory and second R&D site in China

AstraZeneca puts $2.5B toward first vaccine factory and...

Mar 21, 2025  0